Advisory Resource Group Takes $964,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Advisory Resource Group acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 1,947 shares of the medical equipment provider’s stock, valued at approximately $964,000.

Several other hedge funds have also recently bought and sold shares of the company. Castleark Management LLC lifted its position in shares of Intuitive Surgical by 3.4% during the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock worth $47,221,000 after purchasing an additional 2,990 shares in the last quarter. FourThought Financial Partners LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $1,158,000. Longbow Finance SA acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $4,431,000. Prakash Investment Advisors LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $1,201,000. Finally, Alberta Investment Management Corp purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $15,291,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $509.49 on Thursday. The firm’s fifty day moving average price is $527.31 and its 200 day moving average price is $537.92. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The company has a market capitalization of $182.61 billion, a price-to-earnings ratio of 74.71, a price-to-earnings-growth ratio of 5.43 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter last year, the company posted $1.50 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction on Monday, April 28th. The shares were sold at an average price of $515.91, for a total transaction of $96,991.08. Following the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,695,113.84. This trade represents a 3.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction on Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president now owns 2,245 shares in the company, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock valued at $2,611,577 in the last three months. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent research reports. Robert W. Baird cut their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Barclays cut their price target on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Citigroup reiterated a “buy” rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a “buy” rating in a research note on Monday, April 14th. Finally, Truist Financial reduced their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $588.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.